Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
5,619
-183
-3% -$8.91K 0.02% 558
2026
Q1
$249K Sell
5,802
-420
-7% -$18.1K 0.01% 548
2025
Q4
$271K Buy
6,222
+168
+3% +$6.95K 0.02% 526
2025
Q3
$209K Buy
+6,054
New +$243K 0.01% 606
2025
Q2
Sell
-5,460
Closed -$202K 623
2025
Q1
$202K Buy
+5,460
New +$195K 0.02% 485
2016
Q2
Sell
-57,000
Closed -$228K 254
2016
Q1
$228K Buy
+57,000
New +$241K 0.09% 202
2015
Q4
Sell
-40,000
Closed -$224K 262
2015
Q3
$224K Sell
40,000
-22,000
-35% -$120K 0.19% 119
2015
Q2
$231K Buy
62,000
+1,443
+2% +$4.69K 0.1% 198
2015
Q1
$156K Hold
60,557
0.07% 228
2014
Q4
$87K Sell
60,557
-5,359
-8% -$8.35K 0.04% 232
2014
Q3
$101K Buy
+65,916
New +$212K 0.04% 283

Other funds holding EXEL

NWAM LLC's EXEL Position: Q2 2026 in Review

NWAM LLC reduced its Exelixis (EXEL) stake by 3.2% in Q2 2026, selling an estimated $8.91K and leaving 5,619 shares worth $306K. The position accounts for 0.02% of the portfolio, ranked #558.

NWAM LLC first reported a position in EXEL in Q3 2014 and has held it in 11 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • NWAM LLC held 5,619 shares of Exelixis worth $306K as of Q2 2026.
  • NWAM LLC sold 183 Exelixis shares in Q2 2026, an estimated $8.91K.
  • Exelixis made up 0.02% of NWAM LLC's portfolio in Q2 2026, its #558 holding.
  • NWAM LLC first reported a position in Exelixis in Q3 2014 and has held it in 11 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.